NCT00006025 Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma Status COMPLETED Phase PHASE1
NCT00006024 Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma Status COMPLETED Phase PHASE1
NCT00005955 Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors Status COMPLETED Phase PHASE2
NCT00005952 Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT00005951 Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma Status COMPLETED Phase PHASE1
NCT00005815 Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma Status COMPLETED Phase PHASE1/PHASE2
NCT00005812 Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or Lymphoma Status TERMINATED Phase PHASE2
NCT00005637 Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma Status COMPLETED Phase PHASE1
NCT00005597 S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors Status COMPLETED Phase PHASE2
NCT00005037 Temozolomide in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00004204 Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma Status UNKNOWN Phase PHASE2
NCT00004200 Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Status COMPLETED Phase PHASE2
NCT00004113 Temozolomide in Treating Patients With Recurrent Malignant Glioma Status COMPLETED Phase PHASE2
NCT00004106 Temozolomide in Treating Patients With Mycosis Fungoides or Sezary Syndrome Status TERMINATED Phase PHASE2
NCT00004068 Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor Status COMPLETED Phase PHASE2
NCT00003747 Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma Status UNKNOWN Phase PHASE1
NCT00003731 Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors Status COMPLETED Phase PHASE2
NCT00003718 Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma Status UNKNOWN Phase PHASE2